SILVER OAK SECURITIES, INCORPORATED
Broker-DealerPosition in BMY — Bristol Myers Squibb Co
CIK 1080576
JACKSON, TN
Position in BMY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$526,301
-$18,517 QoQ
Shares Held
9,134
+1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,506
of 2,514 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SILVER OAK SECURITIES, INCORPORATED holds $18,688,725 across 10 Drug Manufacturers - General names. BMY ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
25,544 | $6,427,892 | |
| 2 | LLY |
ELI LILLY & Co
|
4,636 | $5,560,557 | |
| 3 | JNJ |
Johnson & Johnson
|
10,822 | $2,748,463 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,556 | $1,227,946 | |
| 5 | NVO |
Novo Nordisk A S
|
12,911 | $618,953 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
9,134 | $526,301 | |
| 7 | AMGN |
Amgen Inc
|
1,418 | $513,486 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,641 | $460,003 |
All Filings in BMY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $526,301 | 9,134 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $544,818 | 8,983 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $369,273 | 6,846 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $476,797 | 10,572 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $291,349 | 6,294 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $391,189 | 6,414 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $395,750 | 6,997 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $205,252 | 3,967 | Shares | Sole | 2024-10-23 | |
| No filing history on record for this holder in this stock. | ||||||